2018

Cassell RJ, Mores KL, Zerfas BL, Mahmoud, AH, Lill MA, Trader TJ, Van Rijn RM, Rubiscolins at naturally occuring G protein-biased delta opioid receptor peptides, Eur Neuropsychopharmacol, (accepted for publication)

Kaur J, Soto-Velasquez M, Ding Z, Van Rijn RM, Watts VJ, Flaherty DP, Optimization of a 1,3,4-oxadiazole series for inhibition of adenylyl cyclase 1 and 8 for the treatment of chronic pain, Eur J Med Chem (accepted for publication)

Mores KL, Cassell RJ, Van Rijn RM, Arrestin recruitment and signaling by G protein-coupled receptor heteromers, Neuropharmacology (accepted for publication)​ 

Alongkronrusmee D, Watts VJ, Van Rijn RM (2018), Bimolecular fluorescence complementation methodology to study G protein-coupled receptor dimerization in living cells, Neuromethods, 140, 205-​221

​Robins MT, Chiang T, Mores KL, Alongkronrusmee, D, Van Rijn RM, (2018) Critical role for Gi/o-protein activity in the dorsal striatum in the reduction of voluntary alcohol intake in C57BL/6 mice, Front. Psychiatry (special topic in opioid research), 9 (112):1-14 

Robins MT, Chiang T, Berry JN, Ko MJ, Ha JE, Van Rijn RM, (2018) Behavioral characterization of beta-arrestin1 knockout mice in anxiety-like and alcohol behaviors, Front. Behav. Neurosci, 12 (54):1-11

Marquez-Gomez R, Robins MT, Guitierrez-Rodelo C, Arias JM, Olivares-Reyes JA, Van Rijn RM, Arias-Montano JA, (2018) Functional histamine H3 and adenosine A2a receptors in recombinant cells and rat striatum, Pharmacol Res, 129:515-525

2017

​Burst TF, Alongkronrusmee D, Soto-Velasquez M, Baldwin TA, Ye Z, Dai M, Dessauer CW, van Rijn RM, Watts VJ (2017). Identification of a selective small molecule inhibitor of type 1 adenylyl cyclase activity with analgesic properties. Sci Signal, 10 (467)

Zeng L, Alongkronrusmee D, van Rijn RM (2017). An Integrated Perspective on Diabetic, Alcoholic, and Drug-Induced Neuropathy etiology and treatment in the United States. J Pain Res, 10: 219-228

2016

Anastasia AD, Selzer CC, Elentably H, Van Rijn RM, Krause JE (2016). Heroin use disoder - The evolving role of the pharmacist, Indiana Pharmacy Alliance continued education #5.

Alongkronrusmee D, Chiang T, Van Rijn RM (2016). Involvement of delta opioid receptors in alcohol withdrawal-induced mechanical allodynia in male C57Bl/6 mice. Drug and Alcohol Dependence, 167, 190-198

Yang S, Ben-Shalom R, Ahn M, Liptak AT, Van Rijn RM, Whistler JL, Bender KJ (2016). Beta-arrestin-dependent dopaminergic regulation of calcium channel activity in the axon initial segment. Cell Report, 16(6), 1518-1526

Robins MT, Lu J, Van Rijn RM (2016). Unique behavioral and neurochemical effects induced by repeated adolescent consumption of caffeine-mixed alcohol in C57BL/6 mice. PLOS ONE, 11(7):e0158189

Robins MT, DeFriel JN, Van Rijn RM (2016). Adolescent intake of caffeinated energy drinks does not affect adult alcohol consumption in C57BL/6 and BALB/c mice. Alcohol, 54, 1-9

Alongkronrusmee D, Chiang T, Van Rijn RM (2016). Delta opioid pharmacology in relation to alcohol behaviors. Handb Exp Pharmacol

Chiang T, Sansuk K, Van Rijn RM (2016). Beta-arrestin 2 dependence of delta opioid receptor agonists is correlated with alcohol intake. British Journal of Pharmacology, 173(2), 332-343

2013

Milan-Lobo L, Enquist J, van Rijn RM, Whistler JL (2013). Anti-analgesic effect of the mu/delta opioid receptor heteromer revealed by ligand-biased antagonism. PLOS One, 8(3) e58362.  

van Rijn RM, Defriel JN, Whistler JL (2013). Pharmacological traits of delta opioid receptors: pitfalls or opportunities? Psychopharmacology (Berl), 228(1) 1-18. 

Harvey JH, van Rijn RM, Whistler JL (2013). A FLIPR assay for evaluating agonists and antagonists of GPCR heterodimers. Methods Mol Biol, 995 43-54.

van Rijn RM, Harvey JH, Brissett DI, DeFriel JN, Whistler JL (2013). Novel screening assay for the selective detection of G-protein-coupled receptor heteromer signaling. J Pharmacol Exp Ther, 344(1) 179-88.

2012

Brissett DI, Whistler JL, van Rijn RM (2012). Contribution of mu and delta opioid receptors to the pharmacological profile of kappa opioid receptor subtypes. Eur J Pain, 16(3) 327-37. 
 
van Rijn RM, Brissett DI, Whistler JL (2012). Distinctive modulation of ethanol place preference by delta opioid receptor-selective agonists. Drug Alcohol Depend, 122(1-2) 156-9.  

van Rijn RM, Brissett, DI, Whistler JL (2012). Emergence of functional spinal delta opioid receptors after chronic ethanol exposure. Biol Psychiatry, 71(3) 232-8.  

2010

van Rijn RM, Brissett DI, Whistler JL (2010). Dual efficacy of delta opioid receptor-selective ligands for ethanol drinking and anxiety. J Pharmacol Exp Ther, 335(1) 133-9.
  
van Rijn RM, Whistler JL, Waldhoer M (2010). Opioid-receptor-heteromer-specific trafficking and pharmacology. Curr Opin Pharmacol, 10(1) 73-9.  

2009

van Rijn RM, Whistler JL (2009). The delta(1) opioid receptor is a heterodimer that opposes the actions of the delta(2) receptor on alcohol intake. Biol Psychiatry, 66(8) 777-84. 

He L, Kim J, Ou C, McFadden W, van Rijn RM, Whistler JL (2009). Methadone antinociception is dependent on peripheral opioid receptors. J Pain, 10(4) 369-79

2008

van Rijn RM, Whistler JL (2008). The only way is up: preventing opioid tolerance by promoting cell surface expression of MOR-DOR heterodimers? Mol Interv, 8(6) 277-80.

---

Do not hesitate to contact us for electronic copies of published articles.